Patent Classification
 

Drug Delivery System, Ceramic-Glass

1. Use of biologically active glass as a drug delivery system

Drug Delivery System, Chemo-Mechanical/Mechanical

1. Drug release from polymer matrices through mechanical stimulation
    
2. Chemo-mechanical expansion delivery system

Drug Delivery System, Chewables

1. Chewable antiplaque confectionery dental composition
    
2. Soft chewable tablets
    
3. Chewable compositions containing a gel-forming extract of psyllium
    
4. Dietary fiber delivery system
    
5. Soluble, gum-containing, coated chewable tablet
    
6. Soft tablet containing high molecular weight polyethylene oxide
    
7. Chewable oral contraceptive
    
8. Chewable product including active ingredient
    
9. Chewable oral unit dosage
    
10. Soft chewable tablet comprising separated active ingredients
     
11. Chewable tablets containing mannitol and aspartame
     
    
12. Soft gelatin capsule
     
    
13. Taste-masked pharmaceutical composition
     
    
14. Chewable soft capsule
     
    
15. Chewable tablet
     
    
16. Gastric acid binding chewing pastilles
     
    
17. Chewable tablet and process for preparation thereof
     
    
18. Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom
     
    
19. Process for forming chewable quickly dispersing comestible unit and product therefrom
     
    
20. Pharmaceutical formulation with effervescent couple

Drug Delivery System, Chewing Gum/Caramels

1. Cholesterol reducing chewing gum composition and method of making the same
    
2. Center-filled chewing gum containing a deliverable form of calcium
    
3. Chewing gum formulation and method of making the same
    
4. Chewing gum composition containing an active ingredient
    
5. Pharmaceutical chewing gum formulations
    
6. Preparation for saliva flow
    
7. Chewing gum composition for effectively eliminating nicotine accumulated in a human body
    
8. Method of controlling release of antimicrobial agents in chewing gum
    
9. Nutraceuticals or nutritional supplements and method of making
    
10. Chewing gum containing calcium
     
11. Chewing gum containing phage associated lytic enzymes for treating streptococcal A infections
     
12. Chewing gum with liquid medium
     
13. Method of making coated chewing gum products containing various antacids
     
14. Process for controlling release of active agents from a chewing gum coating and product thereof
     
15. Coated chewing gum products containing an antigas agent
     
16. Coated chewing gum products containing antacid and method of making
     
17. Coated chewing gum products containing an acid blocker and process of preparing
     
18. Medicated chewing-gum
     
19. Center-filled supplement gum
     
20. Caffeine coated chewing gum product and process of making
     
21. Sugar-free dragee chewing sweets
    
    
22. Medicated chewing gum delivery system for nicotine
    
    
23. Process for manufacturing a pharmaceutical chewing gum
     
    
24. Over-coated chewing gum formulations including tableted center
     
    
25. Gums containing antimicrobial agents
     
    
26. Process for producing hard caramels and tablets
     
    
27. Effervescent chewing gum
     
    
28. Method of controlling release of caffeine in chewing gum

Drug Delivery System, Coating/Enteric Coating

1. Coating compositions for bitterness inhibition
    
2. Sustained release formulations of oxymorphone
    
3. Chromone enteric release formulation
    
4. Stable benzimidazole formulation
    
5. Coated preparation soluble in the lower digestive tract
    
6. High drug load acid labile pharmaceutical composition
    
7. Enteric and colonic delivery using HPMC capsules
    
8. Subcoated simulated capsule-like medicament
    
9. Bioactive agent release coating
    
10. Monolayer sugar-coated tablet and process for preparation thereof
     
11. Modified release coated drug preparation
     
12. Coating for a sustained release pharmaceutical composition
     
13. Pharmaceutical composition having two coating layers
     
14. Edible PGA coating composition
     
15. Chrono delivery formulations and method of use thereof
     
16. Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
     
17. Magnesium plus interactive agent delivery
     
18. Edible PGA coating composition
     
19. Coated medicament forms with controlled active substance release
     
20. Sugar-free pharmaceutical products
     
21. Proliposomal drug delivery system
     
22. Film coating
     
23. Method and apparatus for the coating of substrates for pharmaceutical use
     
24. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
     
25. Method for coating pharmaceutical dosage forms
     
26. Low temperature coatings
     
27. Taste masking rapid release coating system
     
28. Edible coating composition
     
29. Tamper-resistant oral opioid agonist formulations
     
30. Opioid analgesics with controlled active substance release
     
31. Dry-powder film coating composition and method of preparation
     
32. Aqueous dispersion suitable for the production of coatings and binders for solid oral drugs
     
33. Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract
     
34. Preparation capable of releasing drug at target site in intestine
     
35. Gellan gum tablet film coating
     
36. Coating and excipient agent for oral or dermal dosage forms
     
37. Oral pulsed dose drug delivery system
     
38. Taste masking coating composition
     
39. Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
     
40. Polymer film compositions for capsules
     
41. Aqueous film coating with improved properties
     
42. Enteric coating, comprising alginic acid, for an oral preparation
     
43. Acrylic enteric coating compositions
     
44. Gellan gum tablet coating
    
    
45. Pharmaceutical dosage form for pulsatile delivery of methylphenidate
     
    
46. Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
     
    
47. Alginate and gellan gum as tablet coating
     
48. Bubbling enteric coated preparations
     
    
49. Elegant film coating system
     
    
50. Method for coating pharmaceutical dosage forms
     
    
51. Method for the preparation of an enteric coated high drug load pharmaceutical composition
     
    
52. Lubricious, drug-accommodating coating
     
    
53. Subcoated simulated capsule-like medicament
     
    
54. Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
     
    
55. Comestible capsules having flavored coatings
     
    
56. Oral therapy for the treatment of allergies and method of manufacture
     
    
57. Entric-coated pharmaceutical compositions
     
    
58. Delayed release coated tablet of bupropion hydrochloride
     
    
59. Aqueous enteric coating composition and low gastric permeability enteric coating
     
    
60. Tablet containing a coated core
     
    
61. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
     
    
62. Use of water-soluble or water-dispersible polyurethanes as coatings or binders for pharmaceutical presentations
     
    
63. Subcoated simulated capsule-like medicament
     
    
64. Multi-colored medicament
     
    
65. Drug coating with topcoat
     
    
66. Enteric-coated chromium picolinate compositions and uses thereof
     
    
67. Method of coating particles and coated spherical particles
     
    
68. Gelatin spray coating
     
    
69. Polymer coated tablet comprising amoxycillin and clavulanate
     
    
70. Microsphere encapsulation of gene transfer vectors
     
    
71. Enteric film coating compositions, method of coating therewith, and coated forms
     
    
72. Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption
     
    
73. Enteric-coated pharmaceutical compositions of mycophenolate
     
    
74. Encapsulation compositions and methods
     
    
75. Method of making a pharmaceutical dosage form comprising a proton pump inhibitor
     
    
76. Enteric film coating compositions, method of coating therewith, and coated forms
     
    
77. Enteric polymer coated capsule containing dried bacterial culture for supplying lactase
     
    
78. Rapamycin formulations for oral administration
     
    
79. Oral coated active drugs
     
    
80. Method of drug delivery and coated oral dosage forms for use in the method
     
    
81. Dosage forms of risedronate

Drug Delivery System, Colonic/Large Intestinal Delivery

1. System for release in lower digestive tract
    
2. Biologically active oral preparation that can be site-specific released in colon
    
3. Multilayer pharmaceutical product for release in the colon
    
4. Colon-specific drug release system
    
5. Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides Colon-specific drug release system
   
   
6. Colon selective drug delivery composition
    
   
7. Large intestinal delivery composite
    
   
8. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
    
   
9. Colonic drug delivery composition
    
   
10. Colonic delivery of nicotine to treat inflammatory bowel disease
     
    
11. Colonic delivery of protein or peptide compositions

Drug Delivery System, Colorant/Dye/Lakes

1. Ingestibles possessing intrinsic color change
    
2. Use of carotenoid aggregates as colorants
    
3. Use of effect pigments in ingested drugs
    
4. Dye migration

Drug Delivery System, Complexation/Conjugation/Ligand

1. Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy
    
2. Method for preparation of amino acid chelate
    
3. Time-release compositions for delivery of [Cr.sub.3O(carboxylate).sub.6(H.sub.2O).sub.3].sup.+
    
4. Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent
    
5. Multidrug multiligand conjugates for targeted drug delivery
    
6. Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
    
7. Nucleic acid-containing complex
    
8. Photosensitizer conjugates for pathogen targeting
    
9. PEG-LHRH analog conjugates
    
10. Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
     
11. Alprazolam inclusion complexes and pharmaceutical compositions thereof
     
12. Controlled drug delivery system using the conjugation of drug to biodegradable polyester
     
13. Polymeric drug formulations
     
14. Fibrin/fibrinogen-binding conjugate
     
15. Gold-containing chemotherapeutic agents
     
16. Stabilization of cardiac troponin I subunits and complexes
     
17. Polymer conjugates of interferon beta-1a and uses
     
18. Polysaccharide-polypeptide conjugate
     
19. Glycoconjugates and methods
     
20. Complexes of immunoglobulins polysaccharides for oral and transmucosal absorption
     
21. PEG-LHRH analog conjugates
     
22. Sustained release ionic conjugate
     
23. Non-invasive localization of a light-emitting conjugate in a mammal
     
24. Method for increasing the serum half-life of a biologically active molecule
     
25. Composite nanospheres and their conjugates with biomolecules
     
26. Drug-carrier complexes and methods of use thereof
     
27. Biologically active conjugates having a detectable reporter moiety and method of identification of the derivative
     
28. Calcium phosphopeptide complexes
     
29. Lipid matrix-drug conjugates particle for controlled release of active ingredient
     
30. Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments
     
31. Transition metal complexes of n, n',n"trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use
     
32. Process for producing composite preparation containing nucleic acid
     
33. Slow release formulations comprising anionic polysaccharide
     
34. Vasopermeability-enhancing conjugates
     
35. Ionically formulated biomolecule microcarriers
     
36. Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
     
37. Synthesis, characterization, and application of pyridylazo bioconjugates as diagnostic and therapeutic agent
     
38. Potentiation of inclusion complex formation of cyclodextrin derivatives
     
39. Antigen carbohydrate compounds and their use in immunotherapy
     
40. Site protected protein modification
     
41. Site-specific preparation of polyethylene glycol-grf conjugates
     
42. Vasopermeability-enhancing conjugates
     
43. Covalent microparticle-drug conjugates for biological targeting
     
44. Complex of human growth hormone and zinc and use
     
45. Individual medicament dosing conjugate
    
    
46. Methods of preparing low-toxicity drug-lipid complexes
    
    
47. Process for fractionating polyethylene glycol (PEG) --protein adducts and an adduct of PEG and granulocyt-macrophage colony stimulating factor
    
    
48. Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
    
    
49. Stable complexes of poorly soluble compounds in ionic polymers
    
    
50. Conjugate of biologically active compound and polar lipid conjugated to a microparticle for biological targeting
     
    
51. Bioconjugates and delivery of bioactive agents
     
    
52. Complexes to improve oral absorption of poorly absorbable antibiotics
     
    
53. Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them
     
    
54. Methods of forming protein-linked lipidic microparticles, and compositions thereof
     
    
55. Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine
     
    
56. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
     
    
57. Complex of human growth hormone and zinc
     
    
58. Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
     
    
59. Process of making a compound by forming a polymer from a template drug
     
    
60. Stabilized conjugates of uncomplexed subunits of multimeric proteins
     
    
61. Macromolecular complexes for drug delivery
     
    
62. Conjugate of biologically active compound and polar lipid conjugated to a microparticle for biological targeting
     
    
63. Anti-microbial targeting for intracellular pathogens
     
    
64. PVA or PEG conjugates of peptides for epitope-specific immunosuppression
     
    
65. Compositions containing nucleic acids and ligands for therapeutic treatment
     
    
66. Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
     
    
67. Covalent polar lipid conjugates with neurologically active compounds for targeting
     
    
68. Immobilized and activity-stabilized complexes of LHRH antagonists and processes for their preparation
     
    
69. Stable lipid-comprising drug delivery complexes and methods for their production
     
    
70. Lipophilic-polycationic delivery systems

Drug Delivery System, Cyclodextrin Related Dosage Forms

1. Alprazolam inclusion complexes and pharmaceutical compositions thereof
    
2. Non-inclusion cyclodextrin complexes
    
3. Artemisinins with improved stability and bioavailability for therapeutic drug development and application
    
4. Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof
    
5. Preserved pharmaceutical compositions comprising cyclodextrins
    
6. Water-absorbing polymers with supramolecular hollow molecules, method for producing them and use of the same
    
7. Artemisinins with improved stability and bioavailability for therapeutic drug development and application
    
8. Cyclodextrins in dental products
    
9. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
    
10. Production of cyclodextrin complexes
     
11. Method for producing a coenzyme Q10/.gamma.-cyclodextrin complex
     
12. .beta.-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
     
13. Biocleavable micelle compositions for use as drug carriers
     
14. Formulation for the parenteral application of a sodium channel blocker
     
15. Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition
     
16. Compositions and methods for drug delivery using amphiphile binding molecules
     
17. Method of increasing the efficacy of antibiotics by complexing with cyclodextrins
     
18. Detoxication of active pharmaceutical substances using cyclodextrine oligomers
     
19. Cyclodextrin compositions
     
20. Potentiation of inclusion complex formation of cyclodextrin derivatives
     
21. Cyclodextrins preferentially substituted on their primary face by acid or amine functions
     
22. Cyclodextrin stabilized pharmaceutical compositions of bupropion hydrochloride
     
23. Preserved cyclodextrin-containing compositions
    
    
24. Cyclodextrin flavor delivery systems
     
    
25. Cyclodextrins and hydrogen peroxide in dental products
     
    
26. Delivery system for antimethanogenic agents
     
    
27. Cyclodextrins in dental products
     
    
28. Solid, non-deliquescent formulations of sodium valproate
     
    
29. Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof
     
    
30. Method and compositions for solubilization and stabilization of polypeptides, especially proteins
     
    
31. Preservative systems for pharmaceutical compositions containing cyclodextrins
     
    
32. Complexes of gamma-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use
     
    
33. Delivery system for antimethanogenic agents